These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 96733)

  • 1. Tryptophan uptake by Mycobacterium tuberculosis H37Rv: effect of rifampin and ethambutol.
    Sundaram KS; Venkitasubramanian TA
    Antimicrob Agents Chemother; 1978 May; 13(5):726-30. PubMed ID: 96733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antimycobacterial effect of ethambutol and rifampin in vitro and determination of sensitivity of Mycobacterium tuberculosis].
    Gel'berg SI; Dvoskin MI
    Probl Tuberk; 1974; 52(6):82-5. PubMed ID: 4211302
    [No Abstract]   [Full Text] [Related]  

  • 3. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
    Dickinson JM; Aber VR; Mitchison DA
    Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of in vitro and in vivo kinetics with clinical use of isoniazid, ethambutol, and rifampin.
    Jenne JW; Beggs WH
    Am Rev Respir Dis; 1973 Jun; 107(6):1013-21. PubMed ID: 4197230
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of rifampicin and ethambutol on Mycobacterium tuberculosis in vitro].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1973; 51(2):56-61. PubMed ID: 4203996
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug sensitivity of tubercle bacilli to ethambutol and rifampicin determined by the Canetti proportional method].
    Woźniak-Dubla S; Tomaszkiewicz L
    Pneumonol Pol; 1977 Dec; 45(12):785-91. PubMed ID: 414214
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity to Ethambutol and Rifampicin of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):75-9. PubMed ID: 6819093
    [No Abstract]   [Full Text] [Related]  

  • 8. The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
    Iacobino A; Giannoni F; Pardini M; Piccaro G; Fattorini L
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours.
    Kirk SM; Schell RF; Moore AV; Callister SM; Mazurek GH
    J Clin Microbiol; 1998 Jun; 36(6):1568-73. PubMed ID: 9620378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
    Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental in-vitro and in-vivo studies of the antibacterial effect of rifampicin and ethambutol].
    Kozulicyna TI; Korotajev GA
    G Ital Chemioter; 1972; 19(2):7-10. PubMed ID: 4199030
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary drug resistance: A continuing study of tubercle bacilli in a veteran population within the United States. VI. Initial observations on the incidence of resistance to rifampin and ethambutol.
    Hobby GL; Johnson PM; Boytar-Papirnyik V; Wilber J
    Am Rev Respir Dis; 1969 May; 99(5):777-9. PubMed ID: 4978401
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of in-vitro and in-vivo experiments with Mycobacterium tuberculosis in helping to plan chemotherapy regimens.
    Dickinson JM; Mitchison DA
    Tidsskr Nor Laegeforen; 1975 Jun; 95(17-18):1087-9. PubMed ID: 806991
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
    Golyshevskaia VI; El'shanskaia MP
    Probl Tuberk; 1973; 51(12):60-4. PubMed ID: 4205666
    [No Abstract]   [Full Text] [Related]  

  • 15. Observations on the action of rifampin and ethambutol alone and in combination with other antituberculous drugs.
    Hobby GL; Lenert TF
    Am Rev Respir Dis; 1972 Feb; 105(2):292-5. PubMed ID: 4621612
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis.
    Ge F; Zeng F; Liu S; Guo N; Ye H; Song Y; Fan J; Wu X; Wang X; Deng X; Jin Q; Yu L
    J Med Microbiol; 2010 May; 59(Pt 5):567-572. PubMed ID: 20075118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteriological criteria of rifampicin and ethambutol resistance].
    Afanasieva JP
    G Ital Chemioter; 1972; 19(2):16-9. PubMed ID: 4199028
    [No Abstract]   [Full Text] [Related]  

  • 18. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
    Steinbrück PW
    Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies of the criteria of chemoresistance to rifampicin and ethambutol].
    Bogdănescu V; Negulescu E; Ticău S; Vlădescu D
    Ftiziologia; 1973; 22(6):611-21. PubMed ID: 4204427
    [No Abstract]   [Full Text] [Related]  

  • 20. A Diagnostic Algorithm To Investigate Pyrazinamide and Ethambutol Resistance in Rifampin-Resistant Mycobacterium tuberculosis Isolates in a Low-Incidence Setting.
    Andres S; Gröschel MI; Hillemann D; Merker M; Niemann S; Kranzer K
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.